In vitro study has shown that liraglutide exhibits anti-proliferative effects on Michigan Cancer Foundation-7 (MCF-7) BrCa cells when cultured in media derived from obese adipose tissue-derived stem cells (ADSCs-CM), which release cytokines and growth factors that encourage cancer growth and metastasis, and can effectively reduce inflammatory mediators, mitigate the pro-proliferative effects of leptin, and amplify the anti-proliferative impact of adiponectin [46]. This evidence concerns the gene LEP and cancer.